Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2986)
All Articles published online
|
Mar 28, 2009 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yan F, Wang XM, Pan C, Ma QM. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells. World J Gastroenterol 2009; 15(12): 1443-1451 [PMID: 19322916 DOI: 10.3748/wjg.15.1443] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i12/1443.htm |
| Number | Citing Articles |
| 1 |
Yunshan Wang, Guangxin Ma, Qin Wang, Mingxin Wen, Yangyang Xu, Xiuquan He, Pengju Zhang, Yuli Wang, Taomei Yang, Panpan Zhan, Guangwei Wei. Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells. Molecules 2013; 19(1): 159 doi: 10.3390/molecules19010159
|
| 2 |
Feng Yan, Li-Ping Bai, Hua Gao, Chang-Ming Zhu, Li Lin, Xiang-Peng Kang. EGF Reverses Multi-drug Resistance via the p-ERK Pathway in HepG2/ADM and SMMC7721/ADM Hepatocellular Carcinoma Models. Asian Pacific Journal of Cancer Prevention 2014; 15(6): 2619 doi: 10.7314/APJCP.2014.15.6.2619
|
| 3 |
Ping Qiu, Gang Chen, Yuhong Dai, Hong Qiu. Establishment and characterization of an oxaliplatin-resistant hepatic cancer cell line*. Oncology and Translational Medicine 2018; 4(2): 48 doi: 10.1007/s10330-018-0267-7
|
| 4 |
Sonja M. Kessler, Juliane Pokorny, Vincent Zimmer, Stephan Laggai, Frank Lammert, Rainer M. Bohle, Alexandra K. Kiemer. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(4): G328 doi: 10.1152/ajpgi.00005.2012
|
| 5 |
Mansi Garg, Neena Goyal. MAPK1 of Leishmania donovani Modulates Antimony Susceptibility by Downregulating P-Glycoprotein Efflux Pumps. Antimicrobial Agents and Chemotherapy 2015; 59(7): 3853 doi: 10.1128/AAC.04816-14
|
| 6 |
Han Xiao, Ben Wang, Hai‐Xia Xiong, Jia‐Fu Guan, Jian Wang, Tao Tan, Kang Lin, Shu‐Bing Zou, Zhi‐Gang Hu, Kai Wang. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Journal of Cellular Physiology 2021; 236(4): 2572 doi: 10.1002/jcp.30015
|
| 7 |
Wei Wang, Fan Pan, Xinrong Lin, Jiakai Yuan, Chunyu Tao, Rui Wang. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.907331
|
| 8 |
BO TANG, ZHIGAO HU, YANG LI, SHENGGUANG YUAN, ZHENRAN WANG, SHUIPING YU, SONGQING HE. Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU. Molecular Medicine Reports 2016; 13(1): 59 doi: 10.3892/mmr.2015.4511
|
| 9 |
Yun Shi, Si-Ye Wang, Min Yao, Wen-Li Sai, Wei Wu, Jun-Ling Yang, Yin Cai, Wen-Jie Zheng, Deng-Fu Yao. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. World Journal of Gastroenterology 2015; 21(45): 12814-12821 doi: 10.3748/wjg.v21.i45.12814
|
| 10 |
MING MA, LIANMEI ZHAO, GUOGUI SUN, CHAO ZHANG, LIHUA LIU, YANYAN DU, XINGXIAO YANG, BAOEN SHAN. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs. Oncology Reports 2016; 35(5): 3122 doi: 10.3892/or.2016.4622
|
| 11 |
Xue Jiang, Ting Lei, Man Zhang. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533034618769413
|
| 12 |
Aniketh Bishnu, Megha Mehrotra, Ajit Dhadve, Shalini Dimri, Abhijit De, Pritha Ray. Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. Translational Oncology 2021; 14(11): 101193 doi: 10.1016/j.tranon.2021.101193
|
| 13 |
Yu-Jia Chang, Chong-Chi Chiu, Chih-Hsiung Wu, Jane An, Cheng-Chia Wu, Tsan-Zon Liu, Po-Li Wei, Ming-Te Huang. Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma. Annals of Surgical Oncology 2010; 17(6): 1703 doi: 10.1245/s10434-010-0912-8
|
| 14 |
Amir Mehdizadeh, Mohammad Hossein Somi, Masoud Darabi, Mortaza Jabbarpour-Bonyadi. Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma. Molecular Biology Reports 2016; 43(2): 107 doi: 10.1007/s11033-016-3943-9
|
| 15 |
Wen-Tsan Chang, Wangta Liu, Yi-Han Chiu, Bing-Hung Chen, Shih-Chang Chuang, Yen-Chun Chen, Yun-Tzh Hsu, Mei-Jei Lu, Shean-Jaw Chiou, Chon-Kit Chou, Chien-Chih Chiu. A 4-Phenoxyphenol Derivative Exerts Inhibitory Effects on Human Hepatocellular Carcinoma Cells through Regulating Autophagy and Apoptosis Accompanied by Downregulating α-Tubulin Expression. Molecules 2017; 22(5): 854 doi: 10.3390/molecules22050854
|
| 16 |
Lihua Min, Baokun He, Lijian Hui. Mitogen-activated protein kinases in hepatocellular carcinoma development. Seminars in Cancer Biology 2011; 21(1): 10 doi: 10.1016/j.semcancer.2010.10.011
|